RxDoctor Payments Data

Michele Hutchison

Pediatric Endocrinology · Albuquerque, NMNPI 1346201639

Payments from drug & device makers

$142,778in general payments, 2019–2025

Across 121 payments — averaging $1179.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$62K
  • Takeda Pharmaceuticals U.S.A., Inc.$46K
  • Eli Lilly$14K
  • Novo Nordisk Health Care AG$13K
  • Biomarin Pharmaceutical Inc.$5K
  • Insulet Corporation$729
  • plus $2K from 17 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$16

What the payments were for

  • Speaking & faculty fees$3,00039%
  • Travel & lodging$1,48719%
  • Food & beverage$3,07540%
  • Education$951%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pediatric endocrinology providers in New Mexicoto place this figure against a meaningful peer group, so we don't.

Other pediatric endocrinology in Albuquerque

Where these figures come from

Is this you, or does something look wrong? →